Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

SELL
$306.88 - $380.0 $4,910 - $6,080
-16 Reduced 64.0%
9 $3,000
Q3 2023

Oct 11, 2023

SELL
$315.92 - $397.36 $631 - $794
-2 Reduced 7.41%
25 $7,000
Q2 2023

Jul 10, 2023

BUY
$346.15 - $392.09 $3,461 - $3,920
10 Added 58.82%
27 $10,000
Q1 2023

Apr 10, 2023

BUY
$323.56 - $373.36 $4,529 - $5,227
14 Added 466.67%
17 $6,000
Q1 2020

Apr 17, 2020

BUY
$243.44 - $359.98 $730 - $1,079
3 New
3 $0
Q3 2019

Oct 18, 2019

SELL
$294.25 - $341.49 $2,942 - $3,414
-10 Closed
0 $0
Q2 2019

Jul 16, 2019

SELL
$279.29 - $336.89 $2,792 - $3,368
-10 Reduced 50.0%
10 $3,000
Q1 2019

Apr 23, 2019

BUY
$246.18 - $297.25 $3,692 - $4,458
15 Added 300.0%
20 $5,000
Q1 2019

Apr 23, 2019

SELL
$246.18 - $297.25 $3,692 - $4,458
-15 Reduced 75.0%
5 $5,000
Q4 2015

Apr 23, 2018

BUY
N/A
20
20 $2,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.